Lloyd Research Centre (LRC) is a premier Contract Research Organization (CRO) focused on the development of high-quality Finished Dosage Forms (FDFs) for pharmaceutical partners across highly regulated global markets, including the United States, European Union, Australasia, and select emerging regions.

Driven by a team of experienced scientists with a strong track record in formulation development and regulatory compliance, LRC combines global expertise, advanced infrastructure, and a disciplined scientific approach. We deliver robust, scalable, and regulatory-aligned solutions that support our partners in bringing high-quality generic medicines to patients worldwide.